CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA)

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 15000 participants.

Also called NCT07220304

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 15,000 participants (planned count) (from the registry)
Sponsor
Corazon Medical PC (from the registry)
Registry
  • NCT NCT07220304
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07220304. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-12 (anticipated); primary completion 2028-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA)
Acronym
CARE-CCTA
Condition
Atherosclerosis
Condition
Cardiovascular Inflammation
Intervention (Device)
CaRi-Heart® Analysis
Lead sponsor
Corazon Medical PC (class: other)

Record details

Record id
cardio:ct-nct07220304
Content hash
d32377577960b42ebb2f795720c59efce76407429ae930d818b2387d57fb770b